Toxic liver disease with chronic active hepatitis without ascites
ICD-10 K71.50 is a billable code used to indicate a diagnosis of toxic liver disease with chronic active hepatitis without ascites.
Toxic liver disease with chronic active hepatitis without ascites (K71.50) refers to liver damage resulting from exposure to toxic substances, leading to inflammation and chronic hepatitis. The liver, a vital organ in the digestive system, plays a crucial role in metabolizing nutrients, detoxifying harmful substances, and producing bile for digestion. In cases of toxic liver disease, the hepatocytes (liver cells) are damaged, resulting in chronic inflammation characterized by ongoing liver cell injury and necrosis. Patients may present with symptoms such as fatigue, jaundice, abdominal pain, and elevated liver enzymes. The disease can progress to fibrosis and cirrhosis if the toxic exposure continues or is not adequately managed. Diagnostic considerations include a thorough patient history to identify potential toxic exposures, laboratory tests to assess liver function, and imaging studies to evaluate liver structure. A liver biopsy may be necessary to confirm the diagnosis and assess the degree of inflammation and fibrosis. Early diagnosis and intervention are critical to prevent further liver damage and complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K71.50 covers chronic active hepatitis resulting from toxic liver disease, specifically when there is no presence of ascites. This includes liver damage from substances such as alcohol, drugs, or industrial chemicals.
K71.50 should be used when the patient presents with chronic active hepatitis due to toxic exposure without ascites, differentiating it from other liver conditions that may involve ascites or acute liver injury.
Documentation should include a detailed patient history of toxic exposure, laboratory results indicating liver function tests, imaging studies, and any biopsy results confirming chronic active hepatitis.
